Chromogranin A Protein (CHGA) (AA 19-131)
Aperçu rapide pour Chromogranin A Protein (CHGA) (AA 19-131) (ABIN666766)
Antigène
Voir toutes Chromogranin A (CHGA) ProtéinesType de proteíne
Origine
Source
Application
Pureté
-
-
Attributs du protein
- AA 19-131
-
Séquence
- MLPVNSPMNK GDTEVMKCIV EVISDTLSKP SPMPVSQECF ETLRGDERIL SILRHQNLLK ELQDLALQGA KERAHQQKKH SGFEDELSEV LENQSSQAEL KEAVEEPSSK DVME
-
Attributs du produit
- Vasostatin 2 , 19-131aa, Human, Recombinant, E.coli
-
Purification
- > 95% by SDS-PAGE
-
niveau d'endotoxine
- < 1 EU per 1ug of protein (determined by LAL method)
-
-
Vous souhaitez d'autres options pour ce Protein ?
!Découvrez nos protéines personnalisées prédéfinies et nos services de protéines sur mesure !Votre projet nécessite-t-il une personnalisation supplémentaire ? Contactez-nous et découvrez nos solutions protéiques sur mesure
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 20 mM Tris-HCl buffer ( pH 8.0) containing 10 % glycerol
-
Stock
- 4 °C,-20 °C,-80 °C
-
Stockage commentaire
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- Chromogranin A (CHGA)
-
Autre désignation
- Chromogranin A/CHGA
-
Sujet
- Vasostatin 2 is the N-terminal fragment (19-131 aa) derived from the cleavage of chromogranin A (CgA) which is a member of the chromogranin/secretogranin (granins) family of neuroendocrine secretory proteins. Vasostatin 2 has been shown to exert several biological activities on several tissues and organs and exerts a large spectrum of homeostatic actions, including antifungal and antimicrobial effect, modulation of cell adhesion, and inhibition of parathyroid hormone secretion. Recombinant human Vasostatin 2 protein was expressed in E. coli and purified by using conventional chromatography techniques.
-
Poids moléculaire
- 12.8 kDa (114aa) confirmed by MALDI-TOF
-
NCBI Accession
- NP_001266
-
Pathways
- Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling
Antigène
-